These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1267 related articles for article (PubMed ID: 24969297)

  • 1. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
    Merga Y; Campbell BJ; Rhodes JM
    Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease.
    Keita AV; Salim SY; Jiang T; Yang PC; Franzén L; Söderkvist P; Magnusson KE; Söderholm JD
    J Pathol; 2008 Jun; 215(2):135-44. PubMed ID: 18348161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal flora in Crohn's disease and ulcerative colitis - an overview.
    Swidsinski A; Loening-Baucke V; Herber A
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():61-71. PubMed ID: 20224153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease.
    Gullberg E; Söderholm JD
    Ann N Y Acad Sci; 2006 Aug; 1072():218-32. PubMed ID: 17057202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
    World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the intestinal mucosal block in ulcerative colitis and Crohn's disease--immunological and ultrastructural findings, and considerations of the pathogenesis.
    Gebbers JO; Otto HF
    Klin Padiatr; 1985; 197(4):341-8. PubMed ID: 4046492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
    Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
    Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarized production of T-helper cell type 1 cells in Peyer's patches in Crohn's disease.
    Kudo T; Nagata S; Aoyagi Y; Suzuki R; Matsuda H; Ohtsuka Y; Shimizu T; Okumura K; Yamashiro Y
    Digestion; 2004; 70(4):214-25. PubMed ID: 15627769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal mucus barrier in normal and inflamed colon.
    Corazziari ES
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S54-5. PubMed ID: 19300126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.
    Schäffler H; Kaschitzki A; Alberts C; Bodammer P; Bannert K; Köller T; Warnke P; Kreikemeyer B; Lamprecht G
    Int J Colorectal Dis; 2016 May; 31(5):961-971. PubMed ID: 26951181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota and mucosal defense in IBD: an update.
    Stange EF; Schroeder BO
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
    [No Abstract]   [Full Text] [Related]  

  • 19. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
    Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
    J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.
    Hansen R; Russell RK; Reiff C; Louis P; McIntosh F; Berry SH; Mukhopadhya I; Bisset WM; Barclay AR; Bishop J; Flynn DM; McGrogan P; Loganathan S; Mahdi G; Flint HJ; El-Omar EM; Hold GL
    Am J Gastroenterol; 2012 Dec; 107(12):1913-22. PubMed ID: 23044767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.